#regenxbio

3 briefings

FDA Halts Regenxbio Gene Therapy Trial After Spinal Masses Found in Five Patients

Aug 25, 2026, 10:28 PM

FDA Reverses Course Again, Clearing Regenxbio to Resubmit Gene Therapy

Jun 22, 2026, 7:48 PM

Regenxbio Will Resubmit Hunter Syndrome Gene Therapy to FDA — No New Study Required

Jun 22, 2026, 3:22 PM